SCFAs pentanoate and butyrate were discovered to increase the function of mTOR and inhibit class I histone deacetylase activity, which leads to elevated production of effector molecules such as CD25, IFN-γ, and TNF-α, and significantly enhances the anti-tumor activity of T cells (41). Here, IFNG is linked to neoplasm.